(1R,2S,5S)-3-((S)-3,3-dimetil-2-(2,2,2-trifluoroacetamido)Chemicalbookbutanoyl){{1 0}},6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylicacid CAS 2755812-45-2

Deskripsyon Product:

ProductName:(1R,2S,5S)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)Chemicalbookbutanoyl){ {10}},6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylicacid CAS 2755812-45-2

 

Sinonim:

{{0}}Azabicyclo[3.1.0]hexane-2-asid carboxylic, 3-[(2S){-3,3-dimethyl-1- oxo-2-[(2,2,2-trifluoroacetyl)amino]butil]-6,6-dimetil-, (1R,2S,5S)-;

 

Pwopriyete Chimik ak Fizik

Aparans: poud blan

Esè: 99% +

Pwen bouyi: 495.1±45.0 degre

Pka:3.26±{2{2}}.40

Dansite: 1.290±0.06 g/cm³

 

Aplikasyon

Li se entèmedyè Paxlovid. PF-07321332 (nirmatrelvir) se yon plon klinik antiviral oral. Li se yon inibitè kovalan SARS-CoV-2 Mpro (proteaz prensipal, 3CLpro) ki mare ak cysteine145 nan domèn katalitik anzim la. Mpro esansyèl pou replikasyon coronavirus. Anpeche aktivite Mpro bloke replikasyon nan yon etap bonè nan sik lavi viris la. Akòz resanblans estriktirèl ant Mpro lòt coronavirus, PF-07321332 ofri potansyèl aktivite pan-coronavirus. Nan vitro li sijere pou anpeche replikasyon varyant CoV-2 ki gen ladan delta ak omicron.

 

Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

 

Pwodwi anba patant yo ofri pou rezon R & D sèlman. Sepandan, responsablite final la se sèlman nan achtè a.

Baj popilè: (1r,2s,5s)-3-((yo)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)chemicalbookbutanoyl){{1 0}},6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylicacid cas 2755812-45-2, manifaktirè, founisè, faktori, achte, nan stock

• On: Asid kolik CAS 81-25-4
• Pwochen: (1R,2S,5S)-N-((S)-1-amino-1-oxo-3-((S)-2-oxopyrrolidin-3-il)propan{ {10}}il)-3-((S)-3,3-dimetil-2-(2,2,2-trifluoroacetamido)butanoyl )-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide CAS 2755812-81-6